-
1
-
-
0345268688
-
Angiotensin-converting enzyme inhibitors: Mechanisms of action and implications in anesthesia practice
-
Behnia R., Molteni A., Igić R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr. Pharm. Des. 9:2003;763-776.
-
(2003)
Curr. Pharm. Des.
, vol.9
, pp. 763-776
-
-
Behnia, R.1
Molteni, A.2
Igić, R.3
-
2
-
-
0028786552
-
Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation
-
Bonten E.J., Galjart N.J., Willemsen R., Usmany M., Vlak J.M., d'Azzo A. Lysosomal protective protein/cathepsin A. Role of the "linker" domain in catalytic activation. J. Biol. Chem. 270:1995;26441-26445.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 26441-26445
-
-
Bonten, E.J.1
Galjart, N.J.2
Willemsen, R.3
Usmany, M.4
Vlak, J.M.5
D'Azzo, A.6
-
3
-
-
0017184389
-
A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding
-
Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann. Biochem. 72:1976;248-254.
-
(1976)
Ann. Biochem.
, vol.72
, pp. 248-254
-
-
Bradford, M.M.1
-
5
-
-
0035050605
-
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells
-
Clark M.A., Diz D.I., Tallant E.A. Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells. Hypertension. 37:2001;1141-1146.
-
(2001)
Hypertension
, vol.37
, pp. 1141-1146
-
-
Clark, M.A.1
Diz, D.I.2
Tallant, E.A.3
-
6
-
-
0031954590
-
N-domain specific substrates and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE
-
Deddish P., Marcic B., Jackman H.L., Wang H.Z., Skidgel R.A., Erdös E.G. N-domain specific substrates and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 31:1998;912-917.
-
(1998)
Hypertension
, vol.31
, pp. 912-917
-
-
Deddish, P.1
Marcic, B.2
Jackman, H.L.3
Wang, H.Z.4
Skidgel, R.A.5
Erdös, E.G.6
-
7
-
-
0038053724
-
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
-
Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N.et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87:2000;1e-14e.
-
(2000)
Circ. Res.
, vol.87
-
-
Donoghue, M.1
Hsieh, F.2
Baronas, E.3
Godbout, K.4
Gosselin, M.5
Stagliano, N.6
-
8
-
-
0036903274
-
Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin
-
Erdös E.G., Jackman H.L., Brovkovych V., Tan F., Deddish P. Products of angiotensin I hydrolysis by human cardiac enzymes potentiate bradykinin. J. Mol. Cell. Cardiol. 34:2002;1569-1576.
-
(2002)
J. Mol. Cell. Cardiol.
, vol.34
, pp. 1569-1576
-
-
Erdös, E.G.1
Jackman, H.L.2
Brovkovych, V.3
Tan, F.4
Deddish, P.5
-
9
-
-
0032583129
-
Angiotensin-(1-7): A bioactive fragment of the rennin-angiotensin system
-
Ferrario C.M., Iyer S.N. Angiotensin-(1-7): a bioactive fragment of the rennin-angiotensin system. Reg. Peptides. 78:1998;13-18.
-
(1998)
Reg. Peptides.
, vol.78
, pp. 13-18
-
-
Ferrario, C.M.1
Iyer, S.N.2
-
11
-
-
0037240849
-
Properties and distribution of angiotensin I converting enzyme
-
Igić R., Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr. Pharm. Des. 9:2003;697-706.
-
(2003)
Curr. Pharm. Des.
, vol.9
, pp. 697-706
-
-
Igić, R.1
Behnia, R.2
-
13
-
-
0036112468
-
Angiotensin 1-9 and 1-7 release in human heart: Role of cathepsin A
-
Jackman H.L., Massad M.G., Sekosan M., Tan F., Marcic B.M., Brovkovych V.et al. Angiotensin 1-9 and 1-7 release in human heart: role of cathepsin A. Hypertension. 39:2002;976-981.
-
(2002)
Hypertension
, vol.39
, pp. 976-981
-
-
Jackman, H.L.1
Massad, M.G.2
Sekosan, M.3
Tan, F.4
Marcic, B.M.5
Brovkovych, V.6
-
14
-
-
0029099808
-
Carboxypeptidase A isoforms produced by distinct genes of alternative splicing in brain and other extrapancreatic tissues
-
Normant E., Gros C., Schwertz J.C. Carboxypeptidase A isoforms produced by distinct genes of alternative splicing in brain and other extrapancreatic tissues. J. Biol. Chem. 270:1995;20543-20549.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 20543-20549
-
-
Normant, E.1
Gros, C.2
Schwertz, J.C.3
-
15
-
-
0032835393
-
Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation
-
Singh R., Alavi N., Singh A.K., Leehey J.D. Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes. 48:1999;2066-2073.
-
(1999)
Diabetes
, vol.48
, pp. 2066-2073
-
-
Singh, R.1
Alavi, N.2
Singh, A.K.3
Leehey, J.D.4
-
16
-
-
0022480041
-
10-angiotensin I: A potential mechanism of endogenous angiotensin-converting enzyme inhibition
-
10-angiotensin I: a potential mechanism of endogenous angiotensin-converting enzyme inhibition. Biochim. Biophys. Acta. 871:1986;1-5.
-
(1986)
Biochim. Biophys. Acta.
, vol.871
, pp. 1-5
-
-
Snyder, R.A.1
Wintroub, B.U.2
-
17
-
-
0034721906
-
A human homolog of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase
-
Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275:2000;33238-33243.
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 33238-33243
-
-
Tipnis, S.R.1
Hooper, N.M.2
Hyde, R.3
Karran, E.4
Christie, G.5
Turner, A.J.6
|